CHRISTOPHER BARTLETT: Open Payments
NPI 1114975687 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 51 payments from 10 companies in 2025. Trend: 2023 $460 · 2024 $695 · 2025 $926
Food & beverage: $826Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $340 |
| Janssen Biotech, Inc. | 17 | $321 |
| Gilead Sciences, Inc. | 7 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: TREMFYA, RINVOQ, LINZESS, SKYRIZI, MAVYRET, CREON, JOURNAVX, OMVOH.
Industry payments across NV — which companies pay providers there.
